Antibody Engineering And Therapeutics, The Premier Antibody Conference in US

Antibody Engineering And Therapeutics, December 9-13, 2019 in San Diego, CA is the #1 antibody engineering conference for accelerating next generation antibodies to commercial success. With over 135 global speaker presentations, you can expand your pipeline of antibody therapeutics by hearing the most cutting-edge case studies, data and industry updates from leading experts working across the entire spectrum of antibody discovery and development. Find potential partners for research projects via the simple and easy-to-use attendee networking app providing you access to over 1,000 global scientists and executives at the forefront of antibody research. 

This year's trailblazing keynotes include: 
- Janine Schuurman, Ph.D., Vice President, Research, Genmab 
- George Georgiou, Ph.D., Professor, Laura Jennings Turner Chair in Engineering, The University of Texas at Austin 
- Gary Nabel, M.D., Ph.D., Chief Scientific Officer and Senior Vice President, Head, North America R&D Hub, Sanofi 
- Marjolein van Egmond, Ph.D., Professor of Oncology and Inflammation, Amsterdam University Medical Center

Find out more at: www.AntibodyEng.com

Others Details

Time: 8:00 am to 5:00 pm Speakers: Janine Schuurman, Ph.D., Vice President, Research, Genmab, George Georgiou, Ph.D., Professor, Laura Jennings Turner Chair in Engineering, The University of Texas at Austin, Gary Nabel, M.D., Ph.D., Chief Scientific Officer and Senior Vice President, Head, North America R&D Hub, Sanofi, Marjolein van Egmond, Ph.D., Professor of Oncology and Inflammation, Amsterdam University Medical Center